RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 44211
 
  
 
C07K PEPTIDES 21115
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 21185
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 20147
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 7118
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 6234
 
  
 
C07D HETEROCYCLIC COMPOUNDS 5157
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 491
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 2152

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0066,317 DNA-METHYLATION BASED METHOD FOR CLASSIFYING TUMOR SPECIESSep 15, 16Mar 08, 18[C12Q]
2018/0028,583 CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH BEVACIZUMABFeb 10, 16Feb 01, 18[A61K, C07K]
2017/0340,717 MSI-SPECIFIC FRAMESHIFT PEPTIDES (FSP) FOR PREVENTION AND TREATMENT OF CANCERJul 31, 17Nov 30, 17[A61K]
2017/0320,930 CD44V6-DERIVED CYCLIC PEPTIDES FOR TREATING CANCERS AND ANGIOGENESIS RELATED DISEASESDec 07, 15Nov 09, 17[A61K, C07K]
2017/0204,450 METHOD AND ENZYME SOLUTION FOR FLOW-CYTOMETRIC DETECTION OF LIGHT CHAIN RESTRICTIONMay 28, 15Jul 20, 17[C12Q, C12N, G01N]
2017/0065,650 RNA VIRUSES FOR IMMUNOVIROTHERAPYFeb 25, 15Mar 09, 17[A61K, C12N]
2016/0228,504 S100 BASED TREATMENT OF CARDIAC POWER FAlLUREOct 01, 14Aug 11, 16[A61K, C12N, C07K]
2016/0228,587 LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCERApr 18, 16Aug 11, 16[A61K, C07D]
2016/0209,433 MEANS AND METHODS FOR DIAGNOSING HEART FAILURE IN A SUBJECTSep 01, 14Jul 21, 16[G01N, G06F]
2016/0195,500 CHROMATOGRAPHIC DEVICE AND METHODJun 26, 14Jul 07, 16[G01N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9914912 ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseasesFeb 17, 14Mar 13, 18[A61K, C12Q, C12N]
9889169 Cancer therapy with a parvovirus combined with a Bcl-2 inhibitorDec 07, 15Feb 13, 18[A61K]
9879258 Treatment of insulin resistance through inhibitors of transcription factor TSC22D4Jun 17, 14Jan 30, 18[C12Q, C12N, G01N]
9868768 Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liverJan 26, 09Jan 16, 18[A61K, C12N, G01N, C07K]
9861669 Oncolytic virotherapy for prevention of tumor recurrenceMay 19, 10Jan 09, 18[A61K, A61P]
9789130 Method for blocking HIV entry into dendritic cells by inhibiting sialoadhesin-sialyllactose binding interactions with gangliosidesDec 17, 12Oct 17, 17[A61K, G01N, C07K]
9770499 MSI-specific frameshift peptides (FSP) for prevention and treatment of cancerOct 29, 15Sep 26, 17[A61K, C07K]
9700588 Use of parvovirus for eliminating cancer stem cells (CSCs)Jun 29, 11Jul 11, 17[A61K]
9683264 Circulating miRNAs as early detection marker and prognostic markerApr 30, 15Jun 20, 17[C12Q, A61N]
9664684 Methods of treating cancer using chemovirotherapyApr 29, 11May 30, 17[G01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0168,069 Mammalian Dickkopf 3 (DKK3) as Urinary Marker for Chronic Kidney DiseasesAbandonedMar 31, 15Jun 15, 17[G01N]
2017/0128,483 HOST DEPENDENCY FACTORS AS TARGETS FOR ANTIVIRAL THERAPYAbandonedMar 24, 15May 11, 17[A61K, G01N]
2016/0206,413 TOOTHBRUSH ELEMENTAbandonedAug 06, 14Jul 21, 16[A46B, A61C]
2016/0206,699 USE OF INTERLEUKIN 10 MRNA TRANSFECTED MACROPHAGES IN ANTI-INFLAMMATORY THERAPIESAbandonedMar 15, 16Jul 21, 16[A61K, C12N]
2016/0075,752 B-TYPE PLEXIN ANTAGONISTS AND USES THEREOFAbandonedNov 23, 15Mar 17, 16[C07K]
2016/0052,954 COMPOUNDS AND METHODS ASSOCIATED WITH DIFFERENTIAL METHYLATION OF HUMAN PAPILLOMA VIRUS GENOMES IN EPITHELIAL CELLSAbandonedAug 31, 15Feb 25, 16[C07H]
2016/0040,120 In Vitro-Co-CulturesystemAbandonedAug 10, 15Feb 11, 16[C12N]
2015/0211,064 ASSAY AND METHOD FOR THE IDENTIFICATION OF INDIVIDUAL RESPONSIVENESS TO IMMUNOGLOBULIN THERAPYAbandonedJun 06, 12Jul 30, 15[C12Q]
2015/0038,980 ROBOT FOR HOLDING AND FOR HANDLING MEDICAL INSTRUMENTS AND EQUIPMENTAbandonedApr 23, 12Feb 05, 15[A61B]
2015/0011,414 MICRORNA FOR DIAGNOSIS OF PANCREATIC CANCER AND/OR PROGNOSIS OF PATIENTS WITH PANCREATIC CANCER BY BLOOD SAMPLESAbandonedJan 16, 13Jan 08, 15[C12Q]
2014/0234,261 Parvovirus Cancer Therapy and Combination with ChemotherapyAbandonedMar 07, 13Aug 21, 14[A61K]
2014/0203,178 POSITION-SENSITIVE DETECTOR FOR DETECTING PHOTON OR PARTICLE DISTRIBUTIONSAbandonedAug 23, 12Jul 24, 14[G01T]
2014/0207,881 CIRCUIT ARRANGEMENT FOR CONNECTION INTERFACEAbandonedJan 26, 12Jul 24, 14[H04L]
2013/0323,276 MALARIA VACCINES BASED ON PRE-ERYTHROCYTIC ANTIGENS FROM P. FALCIPARUMAbandonedDec 06, 11Dec 05, 13[A61K]
2013/0310,276 MICRORNA FOR DIAGNOSIS OF PANCREATIC CANCERAbandonedDec 21, 11Nov 21, 13[C12Q]
2013/0296,344 CHROMENE DERIVATIVES AND THEIR ANALOGA AS WNT PATHWAY ANTAGONISTSAbandonedNov 11, 11Nov 07, 13[C07D]
2013/0251,783 LIPOSOMES CONTAINING PERMEATION ENHANCERS FOR ORAL DRUG DELIVERYAbandonedSep 14, 12Sep 26, 13[A61K]
2013/0209,403 USE OF INHIBITORS OF PHOSPHOLIPASE A2 FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONAbandonedSep 08, 11Aug 15, 13[A61K]
2013/0189,725 HUMAN IN VITRO MODEL OF THE BLOOD CEREBROSPINAL FLUID BARRIERAbandonedAug 17, 11Jul 25, 13[C12Q]
2013/0129,678 CO-ADMINISTRATION OF A PARVOVIRUS AND A CYTOKINE FOR THERAPY OF PANCREATIC CANCERAbandonedNov 17, 11May 23, 13[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.